As the top engineer at Abbott, a $31 billion heath company, Corlis Murray knows a thing or two about being a successful woman in the STEM world. But it’s not her role managing hundreds of millions of dollars and a hundred thousand employees in 150 coun…
Food and Drug Administrator Dr. Scott Gottlieb will resign, the Trump administration confirmed Tuesday.
Drug maker Abbvie may have to defend the price of its Humira treatment before the U.S. Senate Finance Committee today.
Healthcare stocks have been among the leaders in the market rebound since the December lows. These five investing experts, and contributors to MoneyShow.com, believe this trend will continue and highlight their current favorite stocks in life sciences …
Transformational Business Leaders Interview Series: Miles D. White, Chairman and CEO Abbott Laboratories, the 6th longest tenured CEO among the S&P 100. Under his leadership, he has created approximately $200 billion in shareholder value.
The government shutdown is creating a backlog of hundreds of medical device applications awaiting review at the Food and Drug Administration, triggering a cascade of delays for medical technology, The Advanced Medical Technology Association (AdvaMed) s…
Abbott Laboratories CEO Miles White feels no immediate pressure to engineer major mergers and acquisitions, he told analysts Wednesday.
Medical device makers are pushing for a change in the federal anti-kickback statute to allow companies to fully participate in the shift away from fee-for-service medicine to value-based care.
Abbott Laboratories CEO Miles White appears to have settled on his successor at the diversified healthcare company in medical device business head Robert Ford.
China’s latest retaliatory tariffs have hit $4.7 billion in U.S. medical technology exports, the Advanced Medical Technology Association (AdvaMed) said.
